Olivia Manayan, MD, MPH is a Complex Family Planning fellow at the University of Hawaiʻi. She completed her Master of Public Health at King’s College London and received her MD from the University of Queensland, before joining the University of Hawaiʻi to complete her residency training.

In addition to providing access to abortion care, abortion clinics are a highly utilized access point for other gynecological services. The goal of this interventional study is to provide more access to STI testing for patients who seek abortion care through telemedicine, particularly for those whose access to STI testing is otherwise limited. The main questions it aims to answer are:

• What is the acceptability, feasibility, and utilization of self-collected STI screening at the time of telemedicine medication abortion provision?
• How does the uptake of such a service among patients receiving telemedicine abortion care compare to the population of patients who seek in-person medication abortion care?
• What are the positivity rates for STIs in among patients receiving telemedicine medication abortion care compared to the positivity rates for a contemporaneous, in-clinic population?
• What is the average time to between testing and treatment for patients who test positive for an STI using the self-collection service?
• Researchers will compare the intervention group to a contemporaneous, in-clinic population on uptake of STI screening, as well as on positivity rates for the STIs tested.

Participants will be asked to perform self-swab collection for STI testing for gonorrhea, chlamydia, and trichomonas. They will be instructed to send their specimens to a lab using prepaid postage. Upon completion of sample collection and shipping, they will be asked to complete a survey assessing basic demographic information, as well as acceptability and feasibility of the intervention. Patients who test positive for an STI will be promptly provided/referred to treatment.